However, NADPH oxidases (or other ROS generating systems), in relation to mitochondria, are out of scope of this study, and, based on our strong preclinical work supporting mitochondria-mediated oxidative stress in preeclampsia, we sought to assess mitochondrial function and ROS generation in preeclamptic patients. The gene discussed is FMO5; the disease is preeclampsia.